[Long-term outcome of complex treatment of patients with chronic hematogenic osteomyelitis].
The long-term outcomes of developed complex pathogenetic treatment of 318 patients with chronic hematogenous osteomyelitis were analyzed. This treatment is based on the monitoring of lipid peroxidation and natural antioxidants. The follow-up period was 7 years. The usage of this approach decreased the relapse rate to 11.7% in adults and to 5% in children.
Ali-Zade
Ch A
ChA
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D002648:Child; D002908:Chronic Disease; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006801:Humans; D015227:Lipid Peroxidation; D010019:Osteomyelitis / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D012008:Recurrence; D013997:Time Factors; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000975:Antioxidants